ストックスクリーナーアプリを入手
6.3054
5.08%
0.3304
Novavax Inc (NVAX) 最新ニュース
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Ra - GuruFocus
Novavax First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets - Benzinga
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Rating | NVAX Stock News - GuruFocus
Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up - Yahoo Finance
Analysts Just Shipped An Incredible Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance
Novavax (NVAX) Faces Price Target Cut Amid Regulatory Concerns | NVAX Stock News - GuruFocus
Novavax: Q1 Earnings Snapshot - New Haven Register
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... - Yahoo Finance
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Sur - GuruFocus
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... By GuruFocus - Investing.com Canada
Decoding Novavax Inc (NVAX): A Strategic SWOT Insight - GuruFocus
Novavax (NVAX) Sets Sights on Profitability with Strategic Shifts - GuruFocus
Novavax (NVAX) Shares Surge After Upbeat Q1 Results and Raised R - GuruFocus
Health Care Stocks See Mixed Results In Market Movements - Finimize
Novavax projects $1.025B 2025 revenue framework with focus on partnerships - MSN
Novavax (NVAX) Eyes Resolution with FDA for Covid Vaccine Approval | NVAX Stock News - GuruFocus
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears - Reuters
Why This Shrinking Covid-19 Vaccine Stock Jumped 30% - Barron's
COVID Vaccine Maker Novavax Stock Soars 16%Here's Why - Yahoo Finance
Novavax Q1 2025 slides: Revenue surges to $667M, company raises full-year guidance By Investing.com - Investing.com South Africa
Novavax (NVAX) Set to Release Q1 Earnings with Strong Revenue Gr - GuruFocus
FDA advisory panel to discuss makeup of updated COVID shots - Seeking Alpha
Novavax Hauls in $666M Q1 Windfall, Boosts FY25 Outlook - Yahoo Finance
Thursday's Top 5 Trending Stocks: What's Going On With D-Wave, Novavax, Carvana? - Benzinga
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated By Stocktwits - Investing.com India
Earnings call transcript: Novavax Q1 2025 Surpasses Expectations with Strong Revenue Growth - Investing.com
Novavax Stock Rallies On Upbeat Q1 Earnings, Revised Full-Year Revenue Forecast: Retail’s Elated - MSN
Novavax earnings beat by $3.36, revenue topped estimates - Investing.com
Novavax stock soars 20% as Q1 results crush estimates By Investing.com - Investing.com Australia
Novavax swings to profit on lower expenses related to COVID shots - WHTC
Novavax rises after massive Q1 beat, guidance raise - MSN
Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
NVAX Earnings: Novavax Stock Soars 33% in Pre-Market on Explosive Q1 Profit - TipRanks
Novavax Q1 2025 slides: Revenue surges to $667M, company raises full-year guidance - Investing.com Australia
Novavax (NVAX) Reports Strong Q1 Earnings Boosted by APA Terminations - GuruFocus
Novavax (NVAX) Exceeds Q1 Expectations with Strong Earnings and Revenue - GuruFocus
Novavax (NVAX) Shares Surge After Upbeat Q1 Results and Raised Revenue Outlook - GuruFocus
Novavax Inc. Q1 2025 Earnings: EPS of $0.71, Revenue Surges to $667 Million, Exceeding Estimates - GuruFocus
Novavax stock rises after massive Q1 beat (NVAX:NASDAQ) - Seeking Alpha
Novavax jumps after vaccine maker swings to profit in first quarter - TradingView
Earnings snapshot: Novavax Q1 tops estimates; updates FY25 outlook - Seeking Alpha
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights | NVAX Stock News - GuruFocus
Novavax Swings To Profit As COVID-19 Vaccine Costs Drop - Finimize
NOVAVAX INC SEC 10-Q Report - TradingView
Novavax Reports First Quarter 2025 Financial Results and Operational Highlights - PR Newswire
Novavax, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025 - Longview News-Journal
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22 - marketscreener.com
0.81%
大文字化:
|
ボリューム (24 時間):